Biosafety for Molecular Farming

 
The Independent Science Panel (ISP) is a panel of scientists from many disciplines, committed to the Promotion of Science for the Public Good. Read our statement here


Who's on the ISP

Read who is a member on the ISP. Read More


Articles by the ISP

Read More


Campaigns of the
ISP
1. Sustainable World
2. ISP-FP7
3. ISP Report

“Biosafety standards for Molecular Farming,”


Molecular Farming is primarily focused on the production of biopharmaceutical proteins in crop plants. Field testing of genetically modified (GM) corn, canola , tobacco, alfalfa, safflower, rice and tobacco mosaic virus. Seventy-seven such tests have been undertaken in the United States and a large number in other countries. These tests have been undertaken , for the most part, with extreme secrecy regarding location, nature of the product being tested and the safety considerations of the tests. The few published reviews of the environmental and human safety evaluations of the tests focused mainly on the possibility of pollen flow to nearby crops and weeds and ignored the real hazards of seed transfer by farm machinery and on vehicles of all types along with browsing animals. The likely pollution of surface and groundwater by crop leaves and roots debris and breakdown has been almost entirely ignored event though the pharmaceutical products were active in minute quantity.

Considering acceptable safety standards for undertaking field tests and production of biopharmaceutical crops the following recommendations should be considered:

1. Field tests and production facilities should be fully disclosed to the public in a timely way. Both the location and the nature of the product being grown should be made available to the public and any known deleterious side effects of the product should be disclosed. Public health authorities should be provided methods of detecting the product in environmental samples and in human blood and urine.
2. Production and testing of high potency biopharmaceutical products should be limited to fully isolated green house facilities. The facility should have restricted human contact ans to prevent access by insects and birds. Contact with the soil and groundwater should be controlled and only treated wastewater released from the facility. Most pf the biopharmaceutical products are high value items that can be produced economically in a fully isolated facility. Organic waste from the facility should be incinerated on site.
3. All molecular farming production should undertake full studies on the spread of pollen and seeds from the production sites. Adequate methods for high sensitivity detection of pollutants in surface and groundwater should be made available and studies should be undertaken, if possible , by neutral third parties
Implementation of the standards described above should go a long ways towards making Molecular Farming acceptable by farmers and the public.

 

 
www.indsp.org Web
www.i-sis.org.uk
e-mail:[email protected]
 

© 2003 Independent Science Panel